Search results

Found 30016 matches for

People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.

A woman suffering with rheumatoid arthritis rubs her hands

Meet the team

Community Engagement

Work Experience Placement Information

Grant and Pre-trial Activities Survey

MSD Mediation Service

Building better workplace relationships and equipping people to manage conflict better.

Trueta Bursary - Oxford Summer School 2025

Research Culture Toolkit

New theory for spontaneous reporting of suspected adverse drug reactions to biological therapies

Adverse drug reactions, commonly known as side effects, place a significant burden on health services and account for patient deaths, disease, and extra costs in the UK and worldwide. This research is about the reporting of side effects of biologic medicines on patients.

UK Human Functional Genomics Initiative: Musculoskeletal Cluster

Our research will use genetics to improve our understanding and treatment of musculoskeletal diseases, such as osteoarthritis and carpal tunnel syndrome, which cause more years of disability and pain than any other disease class.